Digoxin
- Product NDC
- 71335-0159
- 11-digit product format
- 713350159
- Labeler code
- 71335
- Product ID
- 71335-0159_7fecc5ac-fa18-4aad-a3f9-89e58e0b997e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076268
- Marketing category
- ANDA
- Marketing start
- 2002-07-26
- Marketing end
- 0000-00-00
- Substance
- DIGOXIN
- Active strength
- 250 ug/1
- Pharmacologic classes
- Cardiac Glycoside [EPC],Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71335-0159-1 | 2022-09-27 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-2 | 2022-09-27 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-3 | 2022-09-27 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-4 | 2022-09-27 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |
| 71335-0159-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1774-f424-e053-dadaa90a57ce | 4b74e214-d971-41f2-9a31-ffacf0a2c031 |